I
SUPN icon

InceptionR’s Supernus Pharmaceuticals SUPN Stock Holding History

InceptionR’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$686K Buy
+14,757
New +$709K 0.17% 230

Other funds holding SUPN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

InceptionR's SUPN Position: Q2 2026 in Review

InceptionR opened a new position in Supernus Pharmaceuticals (SUPN) in Q2 2026: 14,757 shares worth $686K. The stake represents 0.17% of the portfolio and ranks #230 among its holdings.

332 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

  • InceptionR held 14,757 shares of Supernus Pharmaceuticals worth $686K as of Q2 2026.
  • Supernus Pharmaceuticals was a new InceptionR position in Q2 2026.
  • Supernus Pharmaceuticals made up 0.17% of InceptionR's portfolio in Q2 2026, its #230 holding.
  • 332 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on InceptionR's 13F filing for Q2 2026, filed 11 Aug 2026.